Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/1993
11/30/1993US5266314 Insecticide making use of viruses and preparation process thereof
11/25/1993WO1993023569A1 Method and reagent for inhibiting viral replication
11/25/1993WO1993023431A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
11/25/1993CA2135646A1 Method and reagent for inhibiting viral replication
11/24/1993CN1022801C Process for the preparation of canine parvovirus vaccines
11/23/1993US5264356 Regulating retroviral replication, infection, and pathogenesis
11/16/1993US5262359 Method of propagating human paramyxoviruses using continuous cell lines
11/16/1993CA1324332C Empty viral capsid vaccines
11/11/1993WO1993022449A1 Inhibitory factor
11/11/1993WO1993022442A1 Oral infection of insect larvae with pre-occluded baculovirus particles
11/11/1993WO1993022440A1 Cdna sequence of dengue virus serotype 1 (singapore strain)
11/11/1993WO1993022433A2 Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament
11/11/1993CA2134666A1 Cdna sequence of dengue virus serotype 1 (singapore strain)
11/11/1993CA2134443A1 Inhibitory factor
11/09/1993CA1324100C Multiple stage affinity process for isolation of specific cells from a cell mixture
11/09/1993CA1324076C Swine dysentery vaccine
11/04/1993DE4225094A1 Compsn. for gene therapy, esp. of viral infections and tumours - comprises anti-sense DNA or RNA inserted into long terminal repeat or transposable element and e.g. virus envelope as carrier
11/03/1993EP0568178A1 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
11/03/1993EP0567581A1 Cell ablation using trans-splicing ribozymes
10/1993
10/28/1993WO1993021310A1 Attenuated respiratory syncytial virus vaccine compositions
10/28/1993WO1993021306A1 Genetically engineered attenuated viruses
10/28/1993CA2118234A1 Genetically engineered attenuated viruses
10/27/1993EP0567100A1 Mutant respiratory syncytial virus (RSV) vaccines containing same and methods of use
10/27/1993EP0566732A1 Adeno-associated virus-2 basal vectors
10/27/1993EP0566647A1 Improved humanized immunoglobulins
10/27/1993EP0566579A1 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions
10/20/1993EP0565626A1 Fusions of a viral protein and a destructive enzyme
10/19/1993US5254339 Solubilizing antigen; complexing with glycosides containing hydrophobic and hydrophilic domains; isolation; purification
10/14/1993WO1993020220A1 Non-infectious hiv particles and uses therefor
10/14/1993WO1993020189A1 Process for the production of a viable cell culture infected by a multiple sclerosis associated virus
10/14/1993WO1993020188A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus
10/14/1993WO1993017118A3 Defective packaging non-oncoviral vectors based on mpmv and hiv
10/14/1993CA2117884A1 Non-infectious hiv particles and uses therefor
10/13/1993EP0564958A1 Virus solution for utilization in immunoassays
10/13/1993EP0564539A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
10/13/1993CN1077132A Hepatitis A attenuated live vaccine and preparing method thereof
10/12/1993US5252479 Safe vector for gene therapy
10/06/1993EP0563239A1 A truncated interleukin-1 receptor gene for the treatment of arthritis
10/06/1993CN1076865A A novel process for preparing a vaccine for hemorrhagic fever with renal syndrome
09/1993
09/30/1993WO1993019191A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment
09/30/1993WO1993018790A1 Vaccine containing live virus for therapy of viral diseases and malignancies
09/29/1993EP0561890A1 Dna expression systems based on alphaviruses
09/29/1993EP0357709B1 Preservation of viruses
09/29/1993EP0245459B1 T-cell lymphotrophic virus protein and assay
09/28/1993US5248670 Phosphorothioate internucleotide bonds
09/22/1993EP0561525A1 Process for the expression of herpes simplex virus type 1 glycoprotein E and methods of use
09/22/1993EP0561034A2 Direct molecular cloning of a modified eukaryotic cytoplasmic DNA virus genome
09/21/1993CA1322342C Molecular cloning and clones of human b lymphotropic virus (hblv)
09/19/1993CA2090303A1 Process for the expression of herpes simplex virus type 1 glycoprotein 1 and methods of use
09/16/1993WO1993018161A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses
09/16/1993WO1993018145A1 INSECTICIDAL TOXINS FROM THE PARASITIC WASP $i(BRACON HEBETOR)
09/16/1993WO1993017724A1 Viral inactivation method
09/16/1993CA2131150A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses
09/16/1993CA2126970A1 Insectidal toxins from the parasitic wasp bracon hebetor
09/15/1993EP0560156A2 Pseudorabies virus polynucleotids and their use in the production of virus-resistant eucaryotic cells
09/15/1993EP0559884A1 Viral recombinant vectors for expression in muscle cells
09/15/1993EP0559856A1 Antimicrobial preservation of platelets and blood factors
09/14/1993US5245010 Polypeptide of herpes simplex virus vmw 65 protein
09/14/1993US5244799 Preparation of a polymeric hydrogel containing micropores and macropores for use as a cell culture substrate
09/14/1993US5244797 Having DNA polymerase activity
09/12/1993WO1993024632A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids
09/12/1993CA2135618A1 Vectors expressing hybrid viruses, methods of use and novel assays
09/08/1993EP0558944A2 RNA and DNA molecules for producing virus resistance
09/07/1993US5242820 Pathogenic mycoplasma
09/02/1993WO1993017124A1 Reaction-based selection for expression of and concentration of catalytic moieties
09/02/1993WO1993017118A2 Defective packaging non-oncoviral vectors based on mpmv and hiv
09/02/1993WO1993016726A2 Inactivated mycoplasma hyopneumoniae and uses therefor
09/02/1993WO1993016722A1 Antigens protective against echinococcus granulosus infection and vaccines containing such antigens
09/02/1993CA2129982A1 Inactivated mycoplasma hyopneumoniae and uses therefor
09/02/1993CA2125405A1 Reaction-based selection for expression of and concentration of catalytic moieties
09/02/1993CA2117607A1 Defective packaging non-oncoviral vectors based on mpmv and hiv
09/01/1993EP0557427A1 Human rotaviruses, vaccines and methods
09/01/1993EP0557388A1 Diagnosis and treatment of multiple sclerosis
08/1993
08/31/1993US5240703 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
08/31/1993CA1321765C Immunodiagnostic assays using chimeric antigens
08/26/1993DE4206574C1 Fractionation method of parts of hepatitis C virus - by concn. of complexes of virus parts and lipoprotein(s) having low densities useful in hepatitis C virus detection and distinction of variants
08/25/1993EP0556434A2 Process for economically producing a protein by using silkworms
08/25/1993EP0556339A1 Chinese hamster ovary cell retrovirus-like c particles
08/25/1993EP0556288A1 Test for virulent revertants in attenuated live vaccines
08/24/1993US5238613 Microporous materials
08/19/1993WO1993016172A1 Mycobacterial species-specific reporter mycobacteriophages
08/19/1993WO1993015762A1 Feline infectious peritonitis vaccine and method of preparation
08/19/1993CA2129034A1 Mycobacterial species-specific reporter mycobacteriophages
08/19/1993CA2128698A1 Feline infectious peritonitis vaccine and method of preparation
08/18/1993EP0556160A2 Insecticidal toxins from plectreurys tristis
08/18/1993EP0555291A1 Vaccinia vectors, vaccinia genes and expression products thereof
08/18/1993CN1075334A Reconstitued body vaccine and method of prepn. thereof
08/18/1993CA2067837A1 Process for producing economic protein by using silkworms
08/17/1993US5236840 Method for growing crustacean virus in fish cells
08/11/1993WO1993016201A1 Method for testing blood units for viral contamination
08/11/1993EP0554389A1 Molecular clones of hiv-1 and uses thereof
08/05/1993WO1993015207A2 Hepatitis therapeutics
08/05/1993WO1993015108A1 Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
08/05/1993WO1993014785A1 Immunotherapy for recurrent hsv infections
08/05/1993CA2128896A1 Hepatitis therapeutics
08/04/1993EP0553235A1 Targeting viruses and cells for selective internalization by cells
08/03/1993US5232844 Photodynamic inactivation of viruses in cell-containing compositions
08/03/1993US5232694 Canine corona virus vaccine
07/1993
07/28/1993EP0552297A1 Hepatitis c virus antibody
07/27/1993US5230997 Methods of detecting the presence of human herpesvirus-7 infection
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 267